Literature DB >> 10752551

Comparison between acute oral/respiratory and chronic stomatitis/gingivitis isolates of feline calicivirus: pathogenicity, antigenic profile and cross-neutralisation studies.

H Poulet1, S Brunet, M Soulier, V Leroy, S Goutebroze, G Chappuis.   

Abstract

Feline calicivirus (FCV) is a major oral and respiratory pathogen of cats, able to induce subclinical infection as well as acute disease. It is also characterized by a high degree of antigenic variation. This work sought to address the question of the existence of distinct biotypes of FCV. Eight French, 6 British and 9 American FCV isolates, responsible for acute oral/respiratory disease or chronic gingivitis/stomatitis, were compared for their pathogenicity, antigenic profiles and serological relationships. Antigenic profiles were assessed by an indirect immunofluorescence assay with a large panel of characterized monoclonal antibodies. Cross-neutralisation assays were performed with specific cat antisera collected at 30 days p.i., then analysed by calculation of antigenic bilateral relatedness and dominance. Whatever their pathogenic origin, all the isolates induced an acute upper-respiratory tract infection in oronasally infected SPF kittens. Their antigenic profiles were different and did not correlate with their geographical or pathological origin. Cross-neutralisation studies and calculation of the mean bilateral relatedness allowed us to distinguish chronic original isolates from acute original ones. This study did not confirm the existence of FCV biotypes but showed that the chronic carrier state is related to the emergence of antigenically distant viruses.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10752551     DOI: 10.1007/s007050050021

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  7 in total

Review 1.  Calicivirus Infection in Cats.

Authors:  Regina Hofmann-Lehmann; Margaret J Hosie; Katrin Hartmann; Herman Egberink; Uwe Truyen; Séverine Tasker; Sándor Belák; Corine Boucraut-Baralon; Tadeusz Frymus; Albert Lloret; Fulvio Marsilio; Maria Grazia Pennisi; Diane D Addie; Hans Lutz; Etienne Thiry; Alan D Radford; Karin Möstl
Journal:  Viruses       Date:  2022-04-29       Impact factor: 5.818

2.  Comparative efficacy of a recombinant feline interferon omega in refractory cases of calicivirus-positive cats with caudal stomatitis: a randomised, multi-centre, controlled, double-blind study in 39 cats.

Authors:  Philippe R Hennet; Guy A L Camy; David M McGahie; Maxime V Albouy
Journal:  J Feline Med Surg       Date:  2011-08       Impact factor: 2.015

3.  Long-term analysis of feline calicivirus prevalence and viral shedding patterns in naturally infected colonies of domestic cats.

Authors:  Karen P Coyne; Susan Dawson; Alan D Radford; Peter J Cripps; Carol J Porter; Christina M McCracken; Rosalind M Gaskell
Journal:  Vet Microbiol       Date:  2006-09-05       Impact factor: 3.293

Review 4.  An Update on Feline Chronic Gingivostomatitis.

Authors:  Da Bin Lee; Frank J M Verstraete; Boaz Arzi
Journal:  Vet Clin North Am Small Anim Pract       Date:  2020-04-18       Impact factor: 2.093

5.  Multiple Correspondence Analysis on Amino Acid Properties within the Variable Region of the Capsid Protein Shows Differences between Classical and Virulent Systemic Feline Calicivirus Strains.

Authors:  Sylvie Brunet; Cécile Sigoillot-Claude; Daniel Pialot; Hervé Poulet
Journal:  Viruses       Date:  2019-11-23       Impact factor: 5.048

6.  Ability of vaccine strain induced antibodies to neutralize field isolates of caliciviruses from Swedish cats.

Authors:  Jonas Johansson Wensman; Ayman Samman; Anna Lindhe; Jean-Christophe Thibault; Louise Treiberg Berndtsson; Margaret J Hosie
Journal:  Acta Vet Scand       Date:  2015-12-12       Impact factor: 1.695

7.  European molecular epidemiology and strain diversity of feline calicivirus.

Authors:  J Hou; F Sánchez-Vizcaíno; D McGahie; C Lesbros; T Almeras; D Howarth; V O'Hara; S Dawson; A D Radford
Journal:  Vet Rec       Date:  2016-01-25       Impact factor: 2.695

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.